Daiichi Eyes First-Line AML Filings For Vanflyta On Positive Data

Overcoming Past Later-Line Setbacks?

Daiichi Sankyo Shows Confidence in Vanflyta's latest results
Daiichi Sankyo Plans Vanflyta Filings For First-Line AML • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip